AF
IART icon

Advisornet Financial’s Integra LifeSciences IART Stock Holding History

Advisornet Financial’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2
Closed -$44 – 2312
2025
Q1 		$44 Hold
2
– – ﹤0.01% 2144
2024
Q4 		$45 Sell
2
-49
-96% -$1.07K ﹤0.01% 1948
2024
Q3 		$927 Buy
51
+35
+219% +$811 ﹤0.01% 1954
2024
Q2 		$466 Buy
+16
New +$475 ﹤0.01% 1951
2024
Q1 		– Sell
-17
Closed -$740 – 2259
2023
Q4 		$740 Hold
17
– – ﹤0.01% 1983
2023
Q3 		$649 Buy
17
+5
+42% +$210 ﹤0.01% 1921
2023
Q2 		$494 Sell
12
-7
-37% -$337 ﹤0.01% 2055
2023
Q1 		$1.09K Buy
19
+3
+19% +$169 ﹤0.01% 1859
2022
Q4 		$897 Buy
+16
New +$814 ﹤0.01% 1871

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Advisornet Financial's IART Position: Q2 2025 in Review

Advisornet Financial sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 2 shares — an estimated $44 sold.

Advisornet Financial first reported a position in IART in Q4 2022 and held it in 9 quarters. The position peaked at $1.09K in Q1 2023. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.

  • Advisornet Financial reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Advisornet Financial sold 2 Integra LifeSciences shares in Q2 2025, an estimated $44.
  • Advisornet Financial first reported a position in Integra LifeSciences in Q4 2022 and held it in 9 quarters.
  • Advisornet Financial's Integra LifeSciences position peaked at $1.09K in Q1 2023.
  • 208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.

Based on Advisornet Financial's 13F filing for Q2 2025, filed 14 Jul 2025.